News

The annual meeting of the European Society for Medical Oncology (ESMO) will take place from October...

On the Occasion of Clinical Trials Day on May 20, 2026: Clinical trials are considered essential for...

Rare cancers account for 20 to 25 percent of all new cancer diagnoses worldwide, yet patients with...

As the sun rises higher in the sky this spring, UV exposure increases. This should be addressed with...

On April 24, the Investigator-Initiated Trials (IIT) Forum of the NCT Heidelberg brought together...

The Clinical Translational Research Fellowship at NCT Heidelberg is designed for junior clinicians...

At the National Center for Tumor Diseases (NCT) in Heidelberg, Peter Lichter was honored on the...

Desmoplastic small- and round-cell tumor is rare, aggressive, and difficult to treat. Researchers at...

At the NCT, patients and their families can help shape research projects from an early stage. A new...

Press release from the Heidelberg Medical Faculty of the Heidelberg University Professor Dr Jessica...